Transcatheter aortic valve replacement (TAVR) is a treatment option for symptomatic
patients with severe aortic stenosis who are candidates for a bioprosthesis across the entire …

The prevalence of both organic valvular heart disease (VHD) and cardiac arrhythmias is
high in the general population, and their coexistence is common. Both VHD and arrhythmias …

Background Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) and redo
surgical aortic valve replacement (SAVR) represent the 2 treatments for aortic bioprosthesis …

New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis Page 1 Address
for correspondence: Ana Pardo Sanz, MD, PhD, University Hospital Ramón y Cajal, Madrid …

Objectives This study sought to determine, in patients undergoing percutaneous coronary
intervention (PCI) during the work-up pre–transcatheter aortic valve replacement (TAVR): 1) …

Background The impact of pre-existing atrial fibrillation (AF) on outcomes after noncardiac
surgery is not clear. Objectives We aimed to study the impact of AF on the risk of adverse …

Introduction Atrial fibrillation (AF) is associated with an increased risk of stroke. Stroke
prevention with oral anticoagulation (OAC) is recommended in AF patients at increased risk …

Background Patients with rheumatic aortic stenosis (AS) were excluded from transcatheter
aortic valve replacement (TAVR) trials. Objectives The authors sought to examine outcomes …

Transcatheter aortic valve implantation (TAVI) has become an alternative to surgical aortic
valve replacement for patients with symptomatic severe aortic stenosis in elderly and …

Cerebrovascular events (CVE) are among the most feared complications of transcatheter
aortic valve replacement (TAVR). CVE appear difficult to predict due to their multifactorial …